Regulation of receptor signaling by relaxin A chain motifs: derivation of pan-specific and LGR7-specific human relaxin analogs.
Relaxin peptides are important hormones for the regulation of reproductive tissue remodeling and the renal cardiovascular system during pregnancy. Recent studies demonstrated that two of the seven human relaxin family peptides, relaxin H2 (RLN2) and INSL3, signal exclusively through leucine-rich repeat-containing G protein-coupled receptors, LGR7 and LGR8. Although it was well characterized that an RXXXRXXI motif at the RLN2 B chain confers receptor activation activity, it is not clear what roles RLN2 A chain plays in receptor interaction. Analyses of relaxin family genes on syntenic regions of model tetrapods showed that the A chain of RLN2 orthologs exhibited a greater sequence divergence as compared with the receptor-binding domain-containing B chain, foreshadowing a potential role in receptor interactions; hence, defining receptor selectivity in this fast evolving peptide hormone. To test our hypothesis that select residues in the human RLN2 A chain play key roles in receptor interaction, we studied mutant peptides with residue substitution(s) in the A chain. Here, we showed that alanine substitution at the A16 and A17 positions enhances LGR8-activation activity of RLN2, whereas mutation at the A22-23 region (RLN2A22-23) ablates LGR8, but not LGR7, activation activity. In addition, we demonstrated that the functional characteristics of the RLN2A22-23 mutant are mainly attributed to modifications at the PheA23 position. Taken together, our studies indicated that ThrA16, LysA17, and PheA23 constitute part of the receptor-binding interface of human RLN2, and that modification of these residues has led to the generation of novel human RLN2 analogs that would allow selective activation of human LGR7, but not LGR8, in vivo.
Park
Jae-Il
JI
Reproductive Biology and Stem Cell Research Program, Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, California 94305-5317, USA.
Semyonov
Jenia
J
Yi
Wei
W
Chang
Chia Lin
CL
Hsu
Sheau Yu Teddy
SY
D020816:Amino Acid Motifs; D000595:Amino Acid Sequence; D040761:Biomimetic Materials / Q000138:chemical synthesis / Q000737:chemistry; D006801:Humans; D008969:Molecular Sequence Data; D009154:Mutation / Q000235:genetics; D043562:Receptors, G-Protein-Coupled / Q000737:chemistry* / Q000378:metabolism*; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism; D012065:Relaxin / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D016415:Sequence Alignment; D017386:Sequence Homology, Amino Acid; D015398:Signal Transduction; D013379:Substrate Specificity
D043562:Receptors, G-Protein-Coupled; D011994:Recombinant Proteins; D012065:Relaxin
J Biol Chem. 2006 Sep 8;281(36):26136-43
16844694
Genes Dev. 2000 Dec 15;14(24):3075-86
11124800
Nucleic Acids Res. 2003 Jul 1;31(13):3381-5
12824332
J Biol Chem. 2003 Dec 12;278(50):50754-64
14522968
Mol Endocrinol. 2003 Dec;17(12):2639-46
12933905
Mol Cell Endocrinol. 2000 Feb 25;160(1-2):11-6
10715534
Ann Intern Med. 2000 Jun 6;132(11):871-9
10836913
Pharmacol Ther. 2006 Oct;112(1):38-56
16647137
J Biol Chem. 1987 Sep 15;262(26):12496-501
3624270
Mol Endocrinol. 2002 Feb;16(2):244-52
11818498
Endocr Rev. 2004 Apr;25(2):205-34
15082520
Proc Natl Acad Sci U S A. 2004 May 11;101(19):7323-8
15123806
Cancer Res. 2007 May 1;67(9):4399-407
17483354
J Pharmacol Exp Ther. 2005 May;313(2):677-87
15649866
Biochemistry. 2006 Jan 24;45(3):1043-53
16411781
Endocrinology. 2004 Oct;145(10):4712-20
15256493
Ann N Y Acad Sci. 2005 May;1041:82-90
15956690
Mol Endocrinol. 1999 Dec;13(12):2163-74
10598589
J Biol Chem. 2003 Mar 7;278(10):7855-62
12506116
J Biol Chem. 1992 Nov 15;267(32):22957-60
1331071
Mol Cell Biol. 2004 Jan;24(2):687-96
14701741
J Biol Chem. 2008 Jun 20;283(25):17287-97
18434306
Rev Endocr Metab Disord. 2005 Dec;6(4):291-6
16311947
BMC Evol Biol. 2005 Feb 12;5:14
15707501
Oxf Rev Reprod Biol. 1993;15:143-89
8336976
J Biol Chem. 2002 Aug 30;277(35):31283-6
12114498
J Natl Cancer Inst. 2006 Oct 18;98(20):1482-93
17047197
Biol Reprod. 2002 Sep;67(3):699-705
12193374
Biol Reprod. 2000 Sep;63(3):697-703
10952910
J Pept Res. 2004 Feb;63(2):91-8
15009530
Nature. 2000 Nov 23;408(6811):483-8
11100731
Biochemistry. 1999 Mar 9;38(10):3073-8
10074360
J Biol Chem. 2005 Apr 8;280(14):14051-6
15695505
Front Horm Res. 2001;27:105-12
11450422
J Mol Biol. 1991 Sep 5;221(1):15-21
1656049
Curr Opin Rheumatol. 1998 Mar;10(2):123-8
9567207
J Biol Chem. 1999 Aug 6;274(32):22354-8
10428805
Mol Reprod Dev. 2001 Mar;58(3):281-6
11170269
J Biol Chem. 2006 Aug 25;281(34):24889-99
16728398
J Biol Chem. 2002 Jan 11;277(2):1148-57
11689565
Pharm Res. 1993 Jun;10(6):834-8
8257492
Genomics. 1995 Sep 20;29(2):465-70
8666396
J Biol Chem. 1994 May 6;269(18):13124-8
8175738
Genome Res. 2008 Jun;18(6):974-85
18463305
J Biol Chem. 2003 Apr 25;278(17):14798-805
12590147
J Biol Chem. 2003 Dec 12;278(50):50765-70
14522967
Mol Cell Endocrinol. 2003 Aug 29;206(1-2):159-66
12943998
J Biol Chem. 2006 Sep 22;281(38):28287-95
16867980
Trends Biochem Sci. 2002 Feb;27(2):107-9
11852249
Endocrinology. 1999 Jan;140(1):445-53
9886856
Science. 2002 Jan 25;295(5555):671-4
11809971
Br J Pharmacol. 1999 May;127(1):91-8
10369460
J Pept Res. 1999 May;53(5):542-7
10424349
Biol Reprod. 2000 Jun;62(6):1593-9
10819760
Mol Endocrinol. 1992 Sep;6(9):1441-50
1435788
Regul Pept. 2001 Mar 2;97(2-3):139-46
11164949
Biochemistry. 1986 Oct 7;25(20):5998-6004
3790502
Genomics. 1999 Aug 15;60(1):50-6
10458910
J Biol Chem. 1991 Jun 15;266(17):10754-61
2040595